Table 2.
Metabolic characteristics of the cohort categorized according to the use of Diuretics 1
| Use of Diuretics | |||
|---|---|---|---|
| |
No |
Yes |
P
2
|
| (n = 890) |
(n = 71) |
|
|
| Body weight (kg) |
72.9 ± 15.5 |
82.8 ± 17.9 |
< 0.001 |
| BMI (kg/m2) |
27.5 ± 5.2 |
31.5 ± 6.2 |
< 0.001 |
| Circumference: |
|
|
|
| Waist (cm) |
93.6 ± 13.8 |
102.4 ± 18.3 |
< 0.001 |
| Hip (cm) |
104.1 ± 11.7 |
110.0 ± 16.8 |
< 0.001 |
| Systolic BP (mmHg) |
129.1 ± 16.2 |
134.9 ± 17.7 |
0.005 |
| Diastolic BP (mmHg) |
78.6 ± 9.8 |
79.6 ± 9.6 |
0.22 |
| Heart rate (beats/min) |
74.3 ± 11.3 |
72.5 ± 11.6 |
0.18 |
| Random capillary blood glucose (mg/dl) |
87 ± 20 |
95 ± 23 |
0.001 |
| Blood concentration of |
n = 468 |
n = 39 |
|
| Glycated hemoglobin (%) |
5.6 ± 0.43 |
5.8 ± 0.47 |
< 0.001 |
| (mmol/mol) |
37.2 ± 4.7 |
40.2 ± 5.2 |
|
| Glucose (mg/dL) |
90 ± 11 |
99 ± 13 |
< 0.001 |
| Total cholesterol (mg/dL) |
213 ± 39 |
211 ± 43 |
0.69 |
| HDL cholesterol (mg/dL) |
60 ± 15 |
57 ± 12 |
0.52 |
| Triglycerides (mg/dL) |
100 ± 50 |
111 ± 35 |
0.008 |
| LDL cholesterol (mg/dL) |
134 ± 36 |
132 ± 38 |
0.71 |
| Uric acid (mg/dL) |
4.9 ± 1.4 |
5.8 ± 1.7 |
< 0.001 |
| Insulin (μU/mL) |
9.2 ± 5.5 |
13.2 ± 8.3 |
< 0.001 |
| HOMA-I |
2.10 ± 1.41 |
3.31 ± 2.43 |
< 0.001 |
| Creatinine (mg/dL) |
0.83 ± 0.21 |
0.87 ± 0.30 |
0.93 |
| GFR - MDRD (mL/min/1.73 m2) | 92.4 ± 19.1 | 90.8 ± 23.9 | 0.89 |
1 All data are reported as means ± SD.
2 Unpaired Student’s t-test.
BMI: body mass index; BP: blood pressure; GFR: glomerular filtration rate; HDL: high-density lipoproteins; HOMA-I: homeostasis model assessment of insulin resistance; LDL: low-density lipoproteins; MDRD: Modification of Diet in Renal Disease Study.